Statin and Aspirin Use Among Hispanic and Latino Adults at High Cardiovascular Risk: Findings From the Hispanic Community Health Study/Study of Latinos
Autor: | Martha L. Daviglus, Franklyn Gonzalez, Donghong Wu, Robert J. Ostfeld, Jianwen Cai, Jocelyn Wilder, Todd A. Lee, Ramon Durazo-Arvizu, Dima M. Qato, Gregory A. Talavera, Samantha A. Reina |
---|---|
Rok vydání: | 2016 |
Předmět: |
Male
Gerontology Disease 030204 cardiovascular system & hematology 0302 clinical medicine Risk Factors Cardiovascular Disease Mexican Americans Prevalence Coronary Heart Disease Medicine 030212 general & internal medicine Young adult Original Research disparities education.field_of_study Aspirin Cuba Hispanic or Latino Middle Aged Health Services 3. Good health Primary Prevention Cardiovascular Diseases South american Community health Female Cardiology and Cardiovascular Medicine medicine.drug Adult cardiovascular risk Race and Ethnicity Statin Adolescent medicine.drug_class Population statins Young Adult 03 medical and health sciences Humans education Aged business.industry Dominican Republic Puerto Rico Central America Odds ratio South America Hydroxymethylglutaryl-CoA Reductase Inhibitors Hispanic/Latino business Demography |
Zdroj: | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
ISSN: | 2047-9980 |
Popis: | Background Despite variations in the prevalence of cardiovascular disease and related risk factors among US Hispanic/Latino adults of diverse backgrounds, there is little information on whether disparities exist in the use of medications for the primary and secondary prevention of cardiovascular disease. We examined the prevalence of statin and aspirin use among diverse US Hispanic/Latino adults at high cardiovascular risk. Methods and Results A multicenter population‐based study, the Hispanic Community Health Study/Study Of Latinos, included a total of 16 415 participants of Mexican, Puerto Rican, Cuban, Dominican, South American, and Central American backgrounds who were aged 18 to 74 years and enrolled between March 2008 and June 2011. Our analyses were limited to 4139 participants considered to be at high cardiovascular risk. Age‐adjusted prevalence of statin and aspirin use was 25% and 44%, respectively, overall but varied by Hispanic/Latino background among those at high cardiovascular risk; statin use was significantly higher ( P CI 1.30–2.31) to 1.30 (95% CI 0.97–1.75), and with a Dominican background, from an odds ratio of 1.45 (95% CI 1.04–2.02) to 1.07 (95% CI 0.75–1.52), in comparison to their counterparts. Conclusions Among Hispanic/Latino adults of diverse backgrounds, statin use was more prevalent among adults with Puerto Rican and Dominican backgrounds at high cardiovascular risk. These differences in statin use were explained, in part, by differences in insurance coverage. These findings have important implications for the prevention of disparities in cardiovascular outcomes within the growing US Hispanic/Latino population. |
Databáze: | OpenAIRE |
Externí odkaz: |